Havemeyer Place’s Guardant Health GH Stock Holding History

Havemeyer Place’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,655	Closed	-$1.45M	–	582
2026 Q1	$1.45M	Sell	15,655 -3,183	-17%	-$320K	0.17%	236
2025 Q4	$1.92M	Buy	+18,838	New	+$1.69M	0.38%	71

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Havemeyer Place's GH Position: Q2 2026 in Review

Havemeyer Place sold out of Guardant Health (GH) in Q2 2026, closing a stake of 15,655 shares — an estimated $1.45M sold.

Havemeyer Place first reported a position in GH in Q4 2025 and held it in 2 quarters. The position peaked at $1.92M in Q4 2025. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Havemeyer Place reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
Havemeyer Place sold 15,655 Guardant Health shares in Q2 2026, an estimated $1.45M.
Havemeyer Place first reported a position in Guardant Health in Q4 2025 and held it in 2 quarters.
Havemeyer Place's Guardant Health position peaked at $1.92M in Q4 2025.
596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.